Cancer Vaccines in Genitourinary Malignancies: Current Advances and Future Directions
Vaccines · 01.06.2026 · 14 (6) · 497
DOI: 10.3390/vaccines14060497 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Vaccines, online erschienen am 01.06.2026. Verfasst von Haider Altay und 4 weiteren Autor:innen. Beteiligte Einrichtung: Hematology and Medical Oncology, The University of Texas Health Science Center at Tyler, Tyler, TX 75708, USA. Die Arbeit nennt 162 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Therapeutic cancer vaccines are a promising immunotherapy approach in genitourinary (GU) cancers, designed to stimulate antitumor immune responses through antigen-specific T-cell activation. Although agents such as bacillus Calmette–Guérin in bladder cancer and sipuleucel-T in prostate cancer have shown success, vaccine monotherapy has generally produced limited clinical benefit due to tumor heterogeneity, poor immune infiltration, and immunosuppressive tumor microenvironments. Multiple vaccine platforms have demonstrated safety and immunogenicity in prostate, renal cell, and urothelial cancers, but efficacy remains modest. Current strategies focus on multi-antigen targeting, improved antigen presentation, and combination therapies with immune checkpoint inhibitors, radiotherapy, and targeted agents to enhance antitumor activity. Advances in personalized vaccine design and delivery systems are driving progress, though challenges such as manufacturing complexity, cost, and biomarker development remain. Ongoing translational and clinical research will be critical to improving the effectiveness of vaccine-based immunotherapy in GU malignancies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Hematology and Medical Oncology, The University of Texas Health Science Center at Tyler, Tyler, TX 75708, USA.
ORCID-Profile: Ghanshyam H Ghelani
Zitieren
APA
Altay, H., Al-Hashimi, I., Matthews, J., DeAlessandro, G., & Ghelani, G. H. (2026). Cancer Vaccines in Genitourinary Malignancies: Current Advances and Future Directions. Vaccines, 14(6), 497. https://doi.org/10.3390/vaccines14060497
Vancouver
Altay H, Al-Hashimi I, Matthews J, DeAlessandro G, Ghelani GH. Cancer Vaccines in Genitourinary Malignancies: Current Advances and Future Directions. Vaccines. 2026;14(6):497. doi:10.3390/vaccines14060497
BibTeX
@article{Altay2026,
author = {Altay, Haider and Al-Hashimi, Ibrahim and Matthews, Josh and DeAlessandro, Grace and Ghelani, Ghanshyam H},
title = {Cancer Vaccines in Genitourinary Malignancies: Current Advances and Future Directions},
journal = {Vaccines},
year = {2026},
volume = {14},
number = {6},
pages = {497},
doi = {10.3390/vaccines14060497}
}
EUVIMED